N

Neonc Technologies Holdings Inc
D

NTHI

10.650
USD
-0.26
(-2.38%)
مغلق
حجم التداول
403
الربح لكل سهم
0
العائد الربحي
-
P/E
-5
حجم السوق
205,322,607
المقالات

العنوان: Neonc Technologies Holdings Inc

القطاع: Healthcare
الصناعة: Biotechnology
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).